[FG] Khanna Gremmelmeier Nina

Kinoshita, Hannah et al. (2025) ‘T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy’, Transplantation and Cellular Therapy, 31(5), pp. 327–338. Available at: https://doi.org/10.1016/j.jtct.2025.02.019.

Frank, F.A. et al. (2025) ‘Current Concepts in Shoulder Periprosthetic Joint Infections—Are Shoulders the Same as Hips and Knees?’, Journal of Clinical Medicine, 14(8), p. 2578. Available at: https://doi.org/10.3390/jcm14082578.

Schreiber, Peter W. et al. (2025) ‘Surgical Site Infections, Risk Factors, and Outcomes After Liver Transplant’, JAMA Network Open, 8. Available at: https://doi.org/10.1001/jamanetworkopen.2025.1333.

van Delden, C. et al. (2025) ‘The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases Research’, Transplant Infectious Disease, 27(2). Available at: https://doi.org/10.1111/tid.70023.

van den Berg, Jana et al. (2025) ‘Basic Concepts and Indications of CAR T Cells’, Hamostaseologie, 45(1), pp. 14–23. Available at: https://doi.org/10.1055/a-2491-3652.

Erdmann, Joana et al. (2025) ‘Amoxicillin Concentrations in Samples of Musculoskeletal Infections’, Helvetica Chimica Acta, 108(2). Available at: https://doi.org/10.1002/hlca.202400178.

Nyffeler, Ramon et al. (2025) ‘Fracture-related infections of the lower extremity – Analysis of costs and their drivers’, Injury, 56(2), p. 112138. Available at: https://doi.org/10.1016/j.injury.2024.112138.

Dähne, Theo et al. (2025) ‘Herpes simplex virus and drug resistance—comprehensive update on resistance mutations and implications for clinical management: a narrative review’, Clinical Microbiology and Infection [Preprint]. Available at: https://doi.org/10.1016/j.cmi.2025.04.046.

ElAbd, Hesham et al. (2025) ‘T and B cell responses against Epstein–Barr virus in primary sclerosing cholangitis’, Nature Medicine [Preprint]. Available at: https://doi.org/10.1038/s41591-025-03692-w.

Morin, Benedict (2025) Human musculoskeletal Staphylococcus aureus infections – characteristics of host-pathogen interactions and treatment failures. Doctoral Thesis. University of Basel.

König, D. et al. (2024) ‘Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma’, Immuno-Oncology and Technology, 24. Available at: https://doi.org/10.1016/j.iotech.2024.100728.

Kusejko, Katharina et al. (2024) ‘Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study’, BMC Infectious Diseases, 24(1). Available at: https://doi.org/10.1186/s12879-024-10026-7.

Maffei, Enea et al. (2024) ‘Phage Paride can kill dormant, antibiotic-tolerant cells of Pseudomonas aeruginosa by direct lytic replication’, Nature Communications, 15(1). Available at: https://doi.org/10.1038/s41467-023-44157-3.

Bertagnolio, Silvia et al. (2024) ‘WHO global research priorities for antimicrobial resistance in human health’, The Lancet Microbe, 5(11). Available at: https://doi.org/10.1016/S2666-5247(24)00134-4.

Rentsch, Katharina M. et al. (2024) ‘Enhancing Stability and Investigating Target Attainment of Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Insights from In Vitro and In Vivo Evaluations’, Antibiotics, 13(10), p. 970. Available at: https://doi.org/10.3390/antibiotics13100970.

Vock, Isabelle et al. (2024) ‘Quantifying aminoglycoside resistance in extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales clinical isolates: a retrospective cohort study’, Swiss Medical Weekly, 154(10). Available at: https://doi.org/10.57187/s.3904.

Goede, Jeroen S. et al. (2024) ‘Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies’, Swiss Medical Weekly, 154(9). Available at: https://doi.org/10.57187/s.3559.

Palianina, D. et al. (2024) ‘Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo’, Science advances, 10(34). Available at: https://doi.org/10.1126/sciadv.ado2048.

Hofer, Kevin D. et al. (2024) ‘B-cell maturation antigen-directed bispecific antibodies in plasmablastic lymphoma’, British Journal of Haematology, 205(2), pp. 722–725. Available at: https://doi.org/10.1111/bjh.19571.

Neofytos, D. and Khanna, N. (2024) ‘How I treat: Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients’, Transplant Infectious Disease, 26(4). Available at: https://doi.org/10.1111/tid.14332.

Müller-Durovic, Bojana et al. (2024) ‘A metabolic dependency of EBV can be targeted to hinder B cell transformation’, Science (New York, N.Y.), 385(6704), p. eadk4898. Available at: https://doi.org/10.1126/science.adk4898.

König, David et al. (2024) ‘Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes’, Cancer Immunology Research, 12(7), pp. 814–821. Available at: https://doi.org/10.1158/2326-6066.CIR-23-0757.

De Greef, Julien et al. (2024) ‘Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation’, Journal of Infection, 88(6). Available at: https://doi.org/10.1016/j.jinf.2024.106162.

Jantarug, Krittapas et al. (2024) ‘A Far-Red Fluorescent Probe to Visualize Gram-Positive Bacteria in Patient Samples’, ACS Infectious Diseases, 10(5), pp. 1545–1551. Available at: https://doi.org/10.1021/acsinfecdis.4c00060.

Couchepin, Jade et al. (2024) ‘Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS)’, Open Forum Infectious Diseases, 11(5). Available at: https://doi.org/10.1093/ofid/ofae223.

Portillo, V. et al. (2024) ‘Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update’, Open Forum Infectious Diseases, 11(5). Available at: https://doi.org/10.1093/ofid/ofae201.

Salmanton-García, Jon et al. (2024) ‘Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022’, eClinicalMedicine, 71. Available at: https://doi.org/10.1016/j.eclinm.2024.102553.

Hosseini-Moghaddam, Seyed M. et al. (2024) ‘Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020’, American Journal of Transplantation, 24(4), pp. 653–668. Available at: https://doi.org/10.1016/j.ajt.2023.11.003.

Ragozzino, Silvio et al. (2024) ‘Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study’, Bone Marrow Transplantation, 59(2), pp. 278–281. Available at: https://doi.org/10.1038/s41409-023-02157-3.

Søgaard, Kirstine K. et al. (2024) ‘Evaluation of the clinical relevance of the Biofire© FilmArray pneumonia panel among hospitalized patients’, Infection, 52(1), pp. 173–181. Available at: https://doi.org/10.1007/s15010-023-02080-1.

Forrer, Pascal et al. (2024) ‘Unveiling signaling pathways inducing MHC class II expression in neutrophils’, Frontiers in Immunology, 15. Available at: https://doi.org/10.3389/fimmu.2024.1444558.

Sollier, Julie et al. (2024) ‘Revitalizing antibiotic discovery and development through in vitro modelling of in-patient conditions’, Nature Microbiology, 9(1), pp. 1–3. Available at: https://doi.org/10.1038/s41564-023-01566-w.

Agnetti, Jessica et al. (2023) ‘Identification of microorganisms by a rapid PCR panel from positive blood cultures leads to faster optimal antimicrobial therapy – a before-after study’, BMC Infectious Diseases, 23(1). Available at: https://doi.org/10.1186/s12879-023-08732-9.

Arendrup, M.C. et al. (2023) ‘European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study’, Journal of Infection, 87(5), pp. 428–437. Available at: https://doi.org/10.1016/j.jinf.2023.08.001.

Palianina, D. et al. (2023) ‘A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications’, Molecular Therapy Methods and Clinical Development, 30, pp. 147–160. Available at: https://doi.org/10.1016/j.omtm.2023.06.007.

Baur, Katharina et al. (2023) ‘CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas’, Bone Marrow Transplantation, 58(9), pp. 1048–1050. Available at: https://doi.org/10.1038/s41409-023-02016-1.

Baur, Katharina et al. (2023) ‘CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas’, Bone Marrow Transplantation, 58(9), pp. 1048–1050. Available at: https://doi.org/10.1038/s41409-023-02016-1.

Hoenigl M et al. (2023) ‘Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study’, The Lancet Infectious Diseases, 23(6), pp. 751–761. Available at: https://doi.org/10.1016/S1473-3099(22)00872-6.

Neofytos D et al. (2023) ‘Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update’, Open Forum Infectious Diseases, 10(6), p. ofad247. Available at: https://doi.org/10.1093/ofid/ofad247.

Palianina, D. et al. (2023) Stem cell memory EBV-specific T cells control post-transplant lymphoproliferative disease and persist<i>in vivo</i>. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2023.05.30.542809.

Walti, Laura N. et al. (2023) ‘Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland’, JAMA Network Open, 6(4), p. E2310687. Available at: https://doi.org/10.1001/jamanetworkopen.2023.10687.

Schaeffer Thibault et al. (2023) ‘Long-Term Follow-Up after Mycobacterium Chimaera Infection Following Cardiac Surgery: Single-Center Experience’, Journal of Clinical Medicine, 12(3). Available at: https://doi.org/10.3390/jcm12030948.

Busca A et al. (2023) ‘Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry’, Frontiers in Immunology, 14, p. 1125030. Available at: https://doi.org/10.3389/fimmu.2023.1125030.

Criscuolo M et al. (2023) ‘SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report’, Journal of Investigational Allergology and Clinical Immunology, 33(3), pp. 225–227. Available at: https://doi.org/10.18176/jiaci.0845.

Marchesi F et al. (2023) ‘COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)’, Haematologica, 108(1), pp. 22–33. Available at: https://doi.org/10.3324/haematol.2022.280847.

Sava M et al. (2023) ‘Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates’, Bone Marrow Transplantation. Springer Nature, 58(1). Available at: https://doi.org/10.1038/s41409-022-01851-y.

Castellanos-Rueda R et al. (2022) ‘speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing’, Nature Communications, 13(1), p. 6555. Available at: https://doi.org/10.1038/s41467-022-34141-8.

Pham, Truong-Thanh et al. (2022) ‘Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients’, American Journal of Transplantation, 22(12), pp. 3031–3046. Available at: https://doi.org/10.1111/ajt.17184.

Gürtler N et al. (2022) ‘Nosocomial human parainfluenza virus type 3 outbreak in immunocompromised patients, and possible lessons from the SARS-CoV-2 pandemic’, Journal of Hospital Infection. W.B. Saunders Ltd, 129. Available at: https://doi.org/10.1016/j.jhin.2022.07.002.

Palianina, D. et al. (2022) A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell therapy applications. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.10.31.514542.

Weisser, Maja et al. (2022) ‘Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patients’, Transfusion, 62(10), pp. 1997–2011. Available at: https://doi.org/10.1111/trf.17083.

Blaskovich Mark A.T. et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14(662). Available at: https://doi.org/10.1126/scitranslmed.abj238.

Blaskovich MAT et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14(662), p. eabj2381. Available at: https://doi.org/10.1126/scitranslmed.abj238.

Darie, Andrei M et al. (2022) ‘Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial’, The Lancet Respiratory Medicine, 10(9), pp. 877–887. Available at: https://doi.org/10.1016/S2213-2600(22)00086-8.

Weisser, M. et al. (2022) Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-1828291/v1.

Callegari, Ilaria et al. (2022) ‘Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch’, EMBO Reports, 23(7). Available at: https://doi.org/10.15252/embr.202153956.

Averbuch D et al. (2022) ‘Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation’, Clinical Infectious Diseases, 75(1), pp. 88–97. Available at: https://doi.org/10.1093/cid/ciab866.

van den Bogaart L et al. (2022) ‘Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study’, Journal of Infection, 85(1), pp. 1–7. Available at: https://doi.org/10.1016/j.jinf.2022.05.019.

Busca A et al. (2022) ‘COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP’, Blood Advances, 6(7), pp. 2427–2433. Available at: https://doi.org/10.1182/bloodadvances.2021005616.

Cardoso E et al. (2022) ‘Is sleep disordered breathing a risk factor for COVID-19 or vice versa?’, ERJ Open Research, 8(2). Available at: https://doi.org/10.1183/23120541.00034-2022.

Salina, Anna et al. (2022) ‘Multiplex bacterial PCR in the bronchoalveolar lavage fluid of non-intubated patients with suspected pulmonary infection: a quasi-experimental study’, ERJ Open Research, 8(2). Available at: https://doi.org/10.1183/23120541.00595-2021.

Ragozzino S et al. (2022) ‘Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples from Swiss Tertiary Care Hospitals’, Open Forum Infectious Diseases, 9(2), p. ofab638. Available at: https://doi.org/10.1093/ofid/ofab638.

Carere-Sigl, Anja et al. (2022) ‘FimH antagonists prevent biofilm formation on catheter surfaces’, Carbohydrate Chemistry, 45, pp. 519–536. Available at: https://doi.org/10.1039/9781839164538-00519.

Jahn K et al. (2022) ‘Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning’, European Respiratory Journal. European Respiratory Society, 59(1). Available at: https://doi.org/10.1183/13993003.01136-2021.

Palianina, D. (2022) Improving EBV-specific T cell therapy: lineage tracing and EBV stem cell memory T cells . Doctoral Thesis.

Axfors C et al. (2021) ‘Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials’, BMC Infectious Diseases, 21(1), p. 1170. Available at: https://doi.org/10.1186/s12879-021-06829-7.

Kohler, Philipp et al. (2021) ‘Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018’, Antimicrobial Resistance and Infection Control, 10(1). Available at: https://doi.org/10.1186/s13756-021-00918-7.

Leuzinger K et al. (2021) ‘Comparing immunoassays for sars-cov-2 antibody detection in patients with and without laboratory-confirmed sars-cov-2 infection’, Journal of Clinical Microbiology, 59(12), p. e0138121. Available at: https://doi.org/10.1128/JCM.01381-21.

Pagano, Livio et al. (2021) ‘COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)’, Journal of Hematology and Oncology, 14(1). Available at: https://doi.org/10.1186/s13045-021-01177-0.

Rüeger, Sina et al. (2021) ‘The influence of human genetic variation on Epstein–Barr virus sequence diversity’, Scientific Reports, 11(1). Available at: https://doi.org/10.1038/s41598-021-84070-7.

Rüeger, Sina et al. (2021) ‘Author Correction: The influence of human genetic variation on Epstein–Barr virus sequence diversity (Scientific Reports, (2021), 11, 1, (4586), 10.1038/s41598-021-84070-7)’, Scientific Reports, 11(1). Available at: https://doi.org/10.1038/s41598-021-87274-z.

Søgaard KK et al. (2021) ‘Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia’, Journal of Intensive Care, 9(1), p. 10. Available at: https://doi.org/10.1186/s40560-021-00526-y.

Gutiérrez-Gutiérrez, B. et al. (2021) ‘Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients’, Antimicrobial Agents and Chemotherapy, 65(11). Available at: https://doi.org/10.1128/AAC.01102-21.

Adam KM et al. (2021) ‘Trends of the epidemiology of Candidemia in Switzerland: A 15-year FUNGINOS survey’, Open Forum Infectious Diseases, 8(10), p. ofab471. Available at: https://doi.org/10.1093/ofid/ofab471.

Zweifel SA et al. (2021) ‘Long-term clinical and multimodal imaging findings in patients with disseminated mycobacterium chimaera infection’, Journal of Clinical Medicine, 10(18). Available at: https://doi.org/10.3390/jcm10184178.

Di Roberto, R.B. et al. (2021) speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.08.23.457342.

Sava M et al. (2021) ‘Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study’, Swiss Medical Weekly, 151(31), p. w20550. Available at: https://doi.org/10.4414/smw.2021.20550.

Sedlmayer F et al. (2021) ‘5-Fluorouracil blocks quorum-sensing of biofilm-embedded methicillin-resistant Staphylococcus aureus in mice’, Nucleic Acids Research, 49(13), p. e73. Available at: https://doi.org/10.1093/nar/gkab251.

Diebold M et al. (2021) ‘Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study’, Swiss Medical Weekly, 151(29-30), p. w20572. Available at: https://doi.org/10.4414/smw.2021.20572.

Kraljevic M et al. (2021) ‘Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients’, Medical Mycology, 59(7), pp. 701–711. Available at: https://doi.org/10.1093/mmy/myaa106.

Walti LN et al. (2021) ‘Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study’, American Journal of Transplantation, 21(7), pp. 2532–2542. Available at: https://doi.org/10.1111/ajt.16423.

Hinić V et al. (2021) ‘Unexpected Mycoplasma hominis infection in two renal transplant recipients traced back to the same donor by whole-genome sequencing’, European Journal of Clinical Microbiology and Infectious Diseases, 40(5), pp. 1097–1102. Available at: https://doi.org/10.1007/s10096-020-04116-y.

Glampedakis E et al. (2021) ‘Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study’, Clinical Infectious Diseases, 72(8), pp. 1379–1385. Available at: https://doi.org/10.1093/cid/ciaa230.

Leuzinger K et al. (2021) ‘Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures’, Journal of Medical Virology, 93(4), pp. 2374–2384. Available at: https://doi.org/10.1002/jmv.26731.

Janiaud P et al. (2021) ‘Association of Convalescent Plasma Treatment with Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis’, JAMA - Journal of the American Medical Association, 325(12), pp. 1185–1195. Available at: https://doi.org/10.1001/jama.2021.2747.

Leuzinger K et al. (2021) ‘Corrigendum to: Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.’, The Journal of infectious diseases, 223(4), pp. 734–735. Available at: https://doi.org/10.1093/infdis/jiaa667.

Cesaro, S., Ragozzino, S. and Khanna, N. (2021) ‘Polyomavirus, Adenovirus, and Viral Respiratory Diseases’, in Hematologic Malignancies. Springer Science and Business Media Deutschland GmbHinfo@springer-sbm.com (Hematologic Malignancies), pp. 191–219. Available at: https://doi.org/10.1007/978-3-030-57317-1_14.

Durovic A et al. (2021) ‘Two simultaneous cases of disseminated infections with Campylobacter fetus: clinical characteristics and molecular comparison’, Clinical Microbiology and Infection. Elsevier B.V., 27(1). Available at: https://doi.org/10.1016/j.cmi.2020.07.018.

Kusejko K et al. (2020) ‘Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV’, PLoS Biology, 18(12), p. e3000963. Available at: https://doi.org/10.1371/journal.pbio.3000963.

Leuzinger K et al. (2020) ‘Epidemiology of severe acute respiratory syndrome Coronavirus 2 emergence amidst community-acquired respiratory viruses’, Journal of Infectious Diseases, 222(8), pp. 1270–1279. Available at: https://doi.org/10.1093/infdis/jiaa464.

Coste AT et al. (2020) ‘Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland’, Infection, 48(5), pp. 761–766. Available at: https://doi.org/10.1007/s15010-020-01475-8.

Studer U et al. (2020) ‘Incidence of CMV replication and the role of letermovir primary/secondary prophylaxis in the early phase after allogeneic hematopoietic stem cell transplantation ⇓ a single centre study’, Anticancer Research, 40(10), pp. 5909–5917. Available at: https://doi.org/10.21873/anticanres.14611.

Tschopp, Jonathan et al. (2020) ‘First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study’, American Journal of Transplantation, 20(10), pp. 2876–2882. Available at: https://doi.org/10.1111/ajt.16062.

van Delden C et al. (2020) ‘Burden and timeline of infectious diseases in the first year after solid organ transplantation in the swiss transplant cohort study’, Clinical Infectious Diseases, 71(7), pp. E159–E169. Available at: https://doi.org/10.1093/cid/ciz1113.

Balmer, Maria L. et al. (2020) ‘Memory CD8+ T Cells Balance Pro- and Anti-inflammatory Activity by Reprogramming Cellular Acetate Handling at Sites of Infection’, Cell Metabolism, 32(3), pp. 457–467.e5. Available at: https://doi.org/10.1016/j.cmet.2020.07.004.

Vu, Diem-Lan et al. (2020) ‘Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study’, Transplant Infectious Disease, 22(4). Available at: https://doi.org/10.1111/tid.13289.

Olearo F. et al. (2020) ‘Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients’, Open Forum Infectious Diseases, 7(7), p. ofaa246. Available at: https://doi.org/10.1093/ofid/ofaa246.

Erba A et al. (2020) ‘OPAT in Switzerland: single-center experience of a model to treat complicated infections’, Infection, 48(2), pp. 231–240. Available at: https://doi.org/10.1007/s15010-019-01381-8.

Poissy, J. et al. (2020) ‘Risk factors for candidemia: A prospective matched case-control study’, Critical Care, 24(1). Available at: https://doi.org/10.1186/s13054-020-2766-1.

Stemler J. et al. (2020) ‘Baseline chest computed tomography as standard of care in high‐risk hematology patients’, Journal of Fungi, 6(1). Available at: https://doi.org/10.3390/jof6010036.